My watch list  

Lithium succinate

Lithium succinate
Systematic (IUPAC) name
lithium butanedioic acid
CAS number  ?
ATC code D11AX04
PubChem 65248
Chemical data
Formula C4H5LiO4
Mol. mass 124.02 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.


Legal status
Routes  ?

Lithium succinate, the lithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis[1] and proposed for the treatment of anogenital warts.[2]


  1. ^ Leeming JP (1993). "Use of topical lithium succinate in the treatment of seborrhoeic dermatitis". Dermatology (Basel) 187 (2): 149-50. PMID 8358107.
  2. ^ Ward KA, Armstrong KD, Maw RD, Winther MD, Gilburt SJ, Dinsmore WW (1997). "A pilot study to investigate the treatment of anogenital warts with Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)". International journal of STD & AIDS 8 (8): 515-7. PMID 9259500.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Lithium_succinate". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE